Advertisement
week in cancer news
  • June 27: The Week in Cancer News

    Low-dose aspirin reduces cancer risk for people with Lynch syndrome, and breast cancer survivors may have lower risk for Alzheimer’s than the general public.

    by Thomas Celona

  • June 20: The Week in Cancer News

    Surgery to remove fallopian tubes can lower ovarian cancer risk, and NIH staff cuts lead to delays for patients with no other treatment options.

    by Eric Fitzsimmons

  • June 13: The Week in Cancer News

    Researchers explore the causes of lung cancer in never-smokers, and findings support start to colonoscopy screening at age 45.

    by Marci A. Landsmann

  • June 6: The Week in Cancer News

    A blood test can detect breast cancer drug resistance, and a combination treatment improves outcomes in colorectal cancer.

    by Kevin McLaughlin

  • May 30: The Week in Cancer News

    AI can help doctors determine which breast cancer patients qualify for targeted therapy, and cancer deaths among women have increased with rising temperatures in some countries.

    by Thomas Celona

  • May 23: The Week in Cancer News

    Disasters present a threat to cancer care, and understanding prostate cancer screening recommendations after President Joe Biden’s diagnosis.

    by Eric Fitzsimmons

  • May 16: The Week in Cancer News

    Study examines benefit of PARP inhibitors before surgery in BRCA-related breast cancer, and exercise improves sexual function after prostate cancer treatment.

    by Marci A. Landsmann

  • May 9: The Week in Cancer News

    A single dose of HPV vaccine is highly effective, and not all cancers are increasing in people under 50.

    by Kevin McLaughlin

  • May 2: The Week in Cancer News

    Immunotherapy may treat some early-stage cancer patients without the need for surgery, and exercise found to counter many side effects of cancer treatment.

    by Eric Fitzsimmons

  • April 25: The Week in Cancer News

    People with metabolic syndrome may have elevated risk for breast cancer mortality, and immunotherapy keeps lung cancer at bay even after discontinuing treatment.

    by Thomas Celona